Omicron Variant: BioNTech, Moderna Expect Data on Vaccine Protection Soon

BioNTech SE said it expects more data on the Omicron variant within two weeks to help determine whether its vaccine produced with partner Pfizer Inc. would have to be reworked. The vaccine manufacturers said that if necessary they expect to be able to ship a new vaccine tailored to the emerging variant in “approximately 100 days.” Meanwhile Moderna Inc said that it is working to “advance a booster candidate” tailored to Omicron and has also been researching booster shots to protect against multiple variants.

You will be redirected in 2 seconds.